GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $58,736,000 | +328.8% | 270,796 | +128.1% | 0.06% | +366.7% |
| Q4 2020 | $13,699,000 | +8.1% | 118,700 | -8.8% | 0.01% | -7.7% |
| Q3 2020 | $12,674,000 | -22.6% | 130,187 | -2.4% | 0.01% | -31.6% |
| Q2 2020 | $16,368,000 | +44.0% | 133,375 | +2.8% | 0.02% | +5.6% |
| Q1 2020 | $11,367,000 | -46.7% | 129,800 | -36.3% | 0.02% | -28.0% |
| Q4 2019 | $21,313,000 | +67.1% | 203,828 | +83.8% | 0.02% | +56.2% |
| Q3 2019 | $12,756,000 | -32.4% | 110,884 | +1.4% | 0.02% | -33.3% |
| Q2 2019 | $18,859,000 | -47.4% | 109,400 | -48.5% | 0.02% | -48.9% |
| Q1 2019 | $35,830,000 | +150.6% | 212,556 | +44.8% | 0.05% | +135.0% |
| Q4 2018 | $14,300,000 | -47.4% | 146,831 | -6.7% | 0.02% | -37.5% |
| Q3 2018 | $27,171,000 | +171.7% | 157,295 | +119.5% | 0.03% | +166.7% |
| Q2 2018 | $9,999,000 | +343.8% | 71,659 | +258.3% | 0.01% | +300.0% |
| Q1 2018 | $2,253,000 | -85.9% | 20,000 | -83.5% | 0.00% | -86.4% |
| Q4 2017 | $16,013,000 | +30.1% | 121,300 | 0.0% | 0.02% | +22.2% |
| Q3 2017 | $12,310,000 | -0.7% | 121,300 | -1.9% | 0.02% | -10.0% |
| Q2 2017 | $12,402,000 | -31.0% | 123,703 | -16.8% | 0.02% | -35.5% |
| Q1 2017 | $17,979,000 | -53.1% | 148,659 | -56.6% | 0.03% | -52.3% |
| Q4 2016 | $38,319,000 | +94.6% | 342,899 | +131.1% | 0.06% | +91.2% |
| Q3 2016 | $19,691,000 | +118.3% | 148,354 | +50.6% | 0.03% | +112.5% |
| Q2 2016 | $9,019,000 | +79.0% | 98,491 | +41.0% | 0.02% | +77.8% |
| Q1 2016 | $5,039,000 | +52.1% | 69,830 | +46.4% | 0.01% | +80.0% |
| Q4 2015 | $3,312,000 | -71.4% | 47,700 | -62.4% | 0.01% | -70.6% |
| Q3 2015 | $11,580,000 | -36.4% | 126,731 | -14.5% | 0.02% | -37.0% |
| Q2 2015 | $18,215,000 | +403.0% | 148,283 | +273.2% | 0.03% | +440.0% |
| Q1 2015 | $3,621,000 | +434.9% | 39,729 | +297.3% | 0.01% | +400.0% |
| Q4 2014 | $677,000 | -73.7% | 10,000 | -68.7% | 0.00% | -75.0% |
| Q3 2014 | $2,579,000 | +86.3% | 31,899 | +147.3% | 0.00% | +300.0% |
| Q2 2014 | $1,384,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |